A perfect storm hit medtech supply chains across the entire value chain and ecosystem. L.E.K. Consulting addresses the most frequent questions from industry executives. By Monish Rajpal, Jonas Funk, Ilya Trakhtenberg, Sheila Shah, and Daria Kolotiy, L.E.K. Consulting.
The medtech operating environment has encountered unprecedented volatility and shock over the last two to three years. Executives are being forced to address a host of new and intense challenges and the trade-offs they entail. In this article, L.E.K. Consulting addresses the eight most common questions executives have raised over the last several months, and that are top of mind as we move toward the end of 2022 and into 2023. These questions are distilled from conversations L.E.K. Consulting and MedTech Strategist continue to have on this topic.